Early Access

10-QPeriod: Q2 FY2015

HCA Healthcare, Inc. Quarterly Report for Q2 Ended Jun 30, 2015

Filed August 5, 2015For Securities:HCA

Summary

HCA Healthcare, Inc. reported strong financial performance for the second quarter and the first six months of 2015, demonstrating robust revenue growth and increased net income compared to the prior year. Revenues saw a significant increase of 7.2% year-over-year for the quarter, driven by a rise in equivalent admissions and revenue per equivalent admission. This top-line growth translated into improved profitability, with net income attributable to HCA Holdings, Inc. rising by 4.9% for the quarter and a substantial 32.3% for the six-month period. The company also continued its focus on capital allocation through significant share repurchases. While operating expenses, particularly salaries and benefits and supplies, increased, they were managed effectively relative to revenue growth. The company also highlighted its strong liquidity position, supported by operational cash flows and available credit facilities, enabling continued investment in capital expenditures. Despite facing ongoing challenges in the healthcare industry, including regulatory changes and the complexities of reimbursement, HCA Healthcare has shown resilience and a capacity for growth. Investors should note the company's strategic debt management, ongoing share repurchase programs, and commitment to operational efficiency as key indicators of its financial health and future prospects.

Financial Statements
Beta
Revenue$9.90B
Interest Expense$425.00M
Net Income$507.00M
EPS (Basic)$1.22
EPS (Diluted)$1.18
Shares Outstanding (Basic)416.41M
Shares Outstanding (Diluted)429.37M

Key Highlights

  • 1Revenues increased by 7.2% to $9.897 billion for Q2 2015 and by 8.4% to $19.573 billion for the first six months of 2015, compared to the same periods in 2014.
  • 2Net income attributable to HCA Holdings, Inc. increased by 4.9% to $507 million ($1.18 per diluted share) for Q2 2015 and by 32.3% to $1.098 billion ($2.54 per diluted share) for the first six months of 2015.
  • 3Consolidated equivalent admissions increased by 6.0% in Q2 2015 and by 6.9% for the first six months of 2015, indicating growing patient volume.
  • 4The provision for doubtful accounts increased significantly by $307 million in Q2 2015 and $102 million for the first six months of 2015, reflecting challenges in collecting from uninsured patients.
  • 5The company repurchased $940 million worth of its common stock during the first six months of 2015, demonstrating a commitment to returning capital to shareholders.
  • 6Operating expenses, particularly salaries and benefits (45.4% of revenue) and supplies (16.9% of revenue), remain significant cost drivers.
  • 7HCA Healthcare continues to actively manage its debt, engaging in debt retirement and issuance activities during the period, resulting in a pretax loss on retirement of debt of $125 million in Q2 2015.

Frequently Asked Questions